Business Context and Reporting Period
This Form 8-K filing by SANUWAVE Health, Inc. reports corporate governance events occurring on September 20, 2011. The report was signed on September 22, 2011, by Christopher M. Cashman, President and Chief Executive Officer.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on the appointment of a director and associated compensation.
Material Changes
- Board Appointment: Ronald M. Sparks Jr. was elected to the Board of Directors on September 20, 2011.
- Term: Mr. Sparks' term expires at the 2012 annual meeting of shareholders, with plans to nominate him for re-election.
- Compensation Arrangement: In connection with his election, Mr. Sparks was granted a stock option to purchase 25,000 shares of common stock.
- Option Details: The exercise price is $2.95 per share. The options were fully vested upon issuance and expire on September 20, 2021.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, risks, contingencies, or unusual items. It references a press release dated September 21, 2011, as an exhibit but does not summarize its contents within this text.
Investor Verification Checklist
- Verify the total number of outstanding shares and the impact of the 25,000 new options on potential dilution.
- Confirm the current market price of SANUWAVE Health, Inc. stock relative to the $2.95 exercise price.
- Review the referenced Press Release (Exhibit 99.1) for additional context on the strategic rationale for Mr. Sparks' appointment.
- Check the company's latest 10-K or 10-Q for the most recent financial performance data, as this 8-K does not provide it.